Nuclear medicine vendor ADAC Laboratories has adopted a shareholders'rights plan designed to protect its shareholders' interests inthe event of an unsolicited takeover of the Milpitas, CA, company.ADAC said that the plan was not adopted in response to
Nuclear medicine vendor ADAC Laboratories has adopted a shareholders'rights plan designed to protect its shareholders' interests inthe event of an unsolicited takeover of the Milpitas, CA, company.ADAC said that the plan was not adopted in response to any hostiletakeover effort, and the company's board was not aware of anysuch effort.
©1991 - 2001
CMP Media, Inc.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.